BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 37923859)

  • 1. Comparison between the efficacy of terbinafine and itraconazole orally vs. the combination of the two drugs in treating recalcitrant dermatophytosis.
    Hassaan ZRAA; Mohamed HAK; Eldahshan RM; Elsaie ML
    Sci Rep; 2023 Nov; 13(1):19037. PubMed ID: 37923859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Limited effectiveness of four oral antifungal drugs (fluconazole, griseofulvin, itraconazole and terbinafine) in the current epidemic of altered dermatophytosis in India: results of a randomized pragmatic trial.
    Singh S; Chandra U; Anchan VN; Verma P; Tilak R
    Br J Dermatol; 2020 Nov; 183(5):840-846. PubMed ID: 32538466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of oral terbinafine versus itraconazole in treatment of dermatophytic infection of skin - A prospective, randomized comparative study.
    Bhatia A; Kanish B; Badyal DK; Kate P; Choudhary S
    Indian J Pharmacol; 2019; 51(2):116-119. PubMed ID: 31142947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of efficacy and safety of oral terbinafine and itraconazole combination therapy in the management of dermatophytosis.
    Sharma P; Bhalla M; Thami GP; Chander J
    J Dermatolog Treat; 2020 Nov; 31(7):749-753. PubMed ID: 31030594
    [No Abstract]   [Full Text] [Related]  

  • 5. Systemic antifungal therapy for tinea capitis in children.
    Chen X; Jiang X; Yang M; González U; Lin X; Hua X; Xue S; Zhang M; Bennett C
    Cochrane Database Syst Rev; 2016 May; 2016(5):CD004685. PubMed ID: 27169520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of two systemic antifungal agents, itraconazole and terbinafine, for the treatment of dermatophytosis in European hedgehogs (Erinaceus europaeus).
    Bexton S; Nelson H
    Vet Dermatol; 2016 Dec; 27(6):500-e133. PubMed ID: 27620985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short-term itraconazole versus terbinafine in the treatment of tinea pedis or manus.
    Tausch I; Decroix J; Gwiezdzinski Z; Urbanowski S; Baran E; Ziarkiewicz M; Levy G; Del Palacio A
    Int J Dermatol; 1998 Feb; 37(2):140-2. PubMed ID: 9542675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term effectiveness of treatment with terbinafine vs itraconazole in onychomycosis: a 5-year blinded prospective follow-up study.
    Sigurgeirsson B; Olafsson JH; Steinsson JB; Paul C; Billstein S; Evans EG
    Arch Dermatol; 2002 Mar; 138(3):353-7. PubMed ID: 11902986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Terbinafine. An update of its use in superficial mycoses.
    McClellan KJ; Wiseman LR; Markham A
    Drugs; 1999 Jul; 58(1):179-202. PubMed ID: 10439936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic options for the treatment of tinea capitis caused by Trichophyton species: griseofulvin versus the new oral antifungal agents, terbinafine, itraconazole, and fluconazole.
    Gupta AK; Adam P; Dlova N; Lynde CW; Hofstader S; Morar N; Aboobaker J; Summerbell RC
    Pediatr Dermatol; 2001; 18(5):433-8. PubMed ID: 11737692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of itraconazole to treat cutaneous fungal infections in children.
    Gupta AK; Nolting S; de Prost Y; Delescluse J; Degreef H; Theissen U; Wallace R; Marynissen G; De Doncker P
    Dermatology; 1999; 199(3):248-52. PubMed ID: 10592406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Voriconazole is superior to combined itraconazole/isotretinoin therapy and itraconazole monotherapy in recalcitrant dermatophytosis.
    Khattab F; Elkholy BM; Taha M; Abd-Elbaset A; Fawzy M
    Mycoses; 2022 Dec; 65(12):1194-1201. PubMed ID: 35943822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of tinea imbricata: a randomized clinical trial using griseofulvin, terbinafine, itraconazole and fluconazole.
    Wingfield AB; Fernandez-Obregon AC; Wignall FS; Greer DL
    Br J Dermatol; 2004 Jan; 150(1):119-26. PubMed ID: 14746625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Itraconazole and terbinafine in perspective: from petri dish to patient.
    De Doncker P
    J Eur Acad Dermatol Venereol; 1999 Sep; 12 Suppl 1():S10-6; discussion S17. PubMed ID: 10509936
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Itraconazole and terbinafine in perspective. From petri dish to patient.
    De Doncker P; Gupta AK
    Postgrad Med; 1999 Jul; Spec No():6-11. PubMed ID: 10492660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Itraconazole. A reappraisal of its pharmacological properties and therapeutic use in the management of superficial fungal infections.
    Haria M; Bryson HM; Goa KL
    Drugs; 1996 Apr; 51(4):585-620. PubMed ID: 8706596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An open randomized comparative study of oral itraconazole pulse and terbinafine pulse in the treatment of onychomycosis.
    Mishra M; Panda P; Tripathy S; Sengupta S; Mishra K
    Indian J Dermatol Venereol Leprol; 2005; 71(4):262-6. PubMed ID: 16394436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Terbinafine: a review of its use in onychomycosis in adults.
    Darkes MJ; Scott LJ; Goa KL
    Am J Clin Dermatol; 2003; 4(1):39-65. PubMed ID: 12477372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. German randomized double-blind multicentre comparison of terbinafine and itraconazole for the treatment of toenail tinea infection.
    Bräutigam M; Nolting S; Schopf RE; Weidinger G
    Br J Dermatol; 1996 Jun; 134 Suppl 46():18-21: discussion 38. PubMed ID: 8763463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimizing the therapeutic approach in tinea capitis of childhood with itraconazole.
    Möhrenschlager M; Schnopp C; Fesq H; Strom K; Beham A; Mempel M; Thomsen S; Brockow K; Wessner DB; Heidelberger A; Ruhdorfer S; Weigl L; Seidl HP; Ring J; Abeck D
    Br J Dermatol; 2000 Nov; 143(5):1011-5. PubMed ID: 11069511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.